Pursuant to Regulation 47 of the Listing Regulations, Ajanta Pharma has informed that it enclosed copies of financial results of the Company for the quarter and nine months ended 31st December 2025 published in newspapers, Mumbai edition of Business Standard and Mumbai edition of Navakal on 31st January 2026.
The above information is a part of company’s filings submitted to BSE.